Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis : focus on giant cell arteritis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10451/48406 |
Resumo: | © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
id |
RCAP_25da8f329c7d63a0ec940f02f480e522 |
---|---|
oai_identifier_str |
oai:repositorio.ul.pt:10451/48406 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis : focus on giant cell arteritisAutoimmune diseasesGiant cell arteritisSystemic vasculitis© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.Objectives: To analyse the current evidence for the management of large vessel vasculitis (LVV) to inform the 2018 update of the EULAR recommendations. Methods: Two systematic literature reviews (SLRs) dealing with diagnosis/monitoring and treatment strategies for LVV, respectively, were performed. Medline, Embase and Cochrane databases were searched from inception to 31 December 2017. Evidence on imaging was excluded as recently published in dedicated EULAR recommendations. This paper focuses on the data relevant to giant cell arteritis (GCA). Results: We identified 287 eligible articles (122 studies focused on diagnosis/monitoring, 165 on treatment). The implementation of a fast-track approach to diagnosis significantly lowers the risk of permanent visual loss compared with historical cohorts (level of evidence, LoE 2b). Reliable diagnostic or prognostic biomarkers for GCA are still not available (LoE 3b).The SLR confirms the efficacy of prompt initiation of glucocorticoids (GC). There is no high-quality evidence on the most appropriate starting dose, route of administration, tapering and duration of GC (LoE 4). Patients with GCA are at increased risk of dose-dependent GC-related adverse events (LoE 3b). The addition of methotrexate or tocilizumab reduces relapse rates and GC requirements (LoE 1b). There is no consistent evidence that initiating antiplatelet agents at diagnosis would prevent future ischaemic events (LoE 2a). There is little evidence to guide monitoring of patients with GCA. Conclusions: Results from two SLRs identified novel evidence on the management of GCA to guide the 2018 update of the EULAR recommendations on the management of LVV.BMJ Publishing Group, Ltd.Repositório da Universidade de LisboaMonti, SaraAgueda, AnaLuqmani, Raashid AhmedButtgereit, FrankCid, MariaDejaco, ChristianMahr, AlfredPonte, CristinaSalvarani, CarloSchmidt, WolfgangHellmich, Bernhard2021-06-08T12:37:05Z20192019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/48406engRMD Open. 2019 Sep 16;5(2):e00100310.1136/rmdopen-2019-0010032056-5933info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:51:46Zoai:repositorio.ul.pt:10451/48406Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:00:17.975636Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis : focus on giant cell arteritis |
title |
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis : focus on giant cell arteritis |
spellingShingle |
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis : focus on giant cell arteritis Monti, Sara Autoimmune diseases Giant cell arteritis Systemic vasculitis |
title_short |
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis : focus on giant cell arteritis |
title_full |
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis : focus on giant cell arteritis |
title_fullStr |
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis : focus on giant cell arteritis |
title_full_unstemmed |
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis : focus on giant cell arteritis |
title_sort |
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis : focus on giant cell arteritis |
author |
Monti, Sara |
author_facet |
Monti, Sara Agueda, Ana Luqmani, Raashid Ahmed Buttgereit, Frank Cid, Maria Dejaco, Christian Mahr, Alfred Ponte, Cristina Salvarani, Carlo Schmidt, Wolfgang Hellmich, Bernhard |
author_role |
author |
author2 |
Agueda, Ana Luqmani, Raashid Ahmed Buttgereit, Frank Cid, Maria Dejaco, Christian Mahr, Alfred Ponte, Cristina Salvarani, Carlo Schmidt, Wolfgang Hellmich, Bernhard |
author2_role |
author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório da Universidade de Lisboa |
dc.contributor.author.fl_str_mv |
Monti, Sara Agueda, Ana Luqmani, Raashid Ahmed Buttgereit, Frank Cid, Maria Dejaco, Christian Mahr, Alfred Ponte, Cristina Salvarani, Carlo Schmidt, Wolfgang Hellmich, Bernhard |
dc.subject.por.fl_str_mv |
Autoimmune diseases Giant cell arteritis Systemic vasculitis |
topic |
Autoimmune diseases Giant cell arteritis Systemic vasculitis |
description |
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019 2019-01-01T00:00:00Z 2021-06-08T12:37:05Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10451/48406 |
url |
http://hdl.handle.net/10451/48406 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
RMD Open. 2019 Sep 16;5(2):e001003 10.1136/rmdopen-2019-001003 2056-5933 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
BMJ Publishing Group, Ltd. |
publisher.none.fl_str_mv |
BMJ Publishing Group, Ltd. |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134550000926720 |